Condition 1: Pain intensity. Condition 2: heart rate. Acute pain, not elsewhere classified
Conditions
Interventions
Intervention 1: Intervention group: In the eye protection group, eye protection will be placed on the infant from 15 minutes before the pentavalent vaccine injection to 15 minutes after the pentavalen
Sponsors
Arak University of Medical Sciences
Eligibility
Sex/Gender
All
Age
5 Months to 6 Months
Inclusion criteria
Inclusion criteria: Absence of congenital anomalies and genetic disorders Not receiving painkillers that affect the physiological and behavioral state of the child, such as anticonvulsants and narcotic sedatives Not having a painful procedure at least one hour before the intervention
Exclusion criteria
Exclusion criteria: Extreme restlessness of the child Presence of an abnormality in the facial area (cleft lip, cleft palate)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: During vaccine injection and 15 minutes after injection. Method of measurement: Pain intensity is an unpleasant sensory and emotional experience associated with actual or potential tissue damage. In this study, the intensity of infant pain during vaccine injection and 15 minutes after is measured by the FLACC scale.;Heart rate. Timepoint: 15 minutes before, during and 15 minutes after the injection. Method of measurement: Heart rate: The number of times the heart beats in a given period of time, usually in one minute. In this study, the infant's heart rate will be measured 15 minutes before, during and 15 minutes after the injection using C29 pulse oximetry. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMahbobeh Sajadi
Arak University of Medical Sciences
Outcome results
None listed